PAPER Túnez I, Collado JA, Medina FJ, Peña J, Del C Muñoz M, Jimena I, Franco F, Rueda I, Feijóo M, Muntané J, Montilla P
SEARCH RESULTS
330710 RESULTS
PAPER Hansson AC, Sommer WH, Metsis M, Strömberg I, Agnati LF, Fuxe K
Corticosterone actions on the hippocampal brain-derived neurotrophic factor expression are mediated by exon IV promoter.
J Neuroendocrinol. 2006 Feb;18(2):104-14. PubMed: 16420279PAPER Mao R, Wang X, Spitznagel EL, Frelin LP, Ting JC, Ding H, Kim JW, Ruczinski I, Downey TJ, Pevsner J
Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart.
Genome Biol. 2005;6(13):R107. PubMed: 16420667PAPER Shumyatsky GP, Malleret G, Shin RM, Takizawa S, Tully K, Tsvetkov E, Zakharenko SS, Joseph J, Vronskaya S, Yin D, Schubart UK, Kandel ER, Bolshakov VY
stathmin, a gene enriched in the amygdala, controls both learned and innate fear.
Cell. 2005 Nov 18;123(4):697-709. PubMed: 16286011PAPER Khosravani H, Altier C, Zamponi GW, Colicos MA
The Arg473Cys-neuroligin-1 mutation modulates NMDA mediated synaptic transmission and receptor distribution in hippocampal neurons.
FEBS Lett. 2005 Dec 5;579(29):6587-94. PubMed: 16298368PAPER Bohnen NI, Albin RL, Koeppe RA, Wernette KA, Kilbourn MR, Minoshima S, Frey KA
Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease.
J Cereb Blood Flow Metab. 2006 Sep;26(9):1198-212. PubMed: 16421508PAPER Battista D, Ferrari CC, Gage FH, Pitossi FJ
Neurogenic niche modulation by activated microglia: transforming growth factor beta increases neurogenesis in the adult dentate gyrus.
Eur J Neurosci. 2006 Jan;23(1):83-93. PubMed: 16420418PAPER Hoffmann V, Kuhn W, Schimrigk S, Islamova S, Hellwig K, Lukas C, Brune N, Pöhlau D, Przuntek H, Müller T
Repeat intrathecal triamcinolone acetonide application is beneficial in progressive MS patients.
Eur J Neurol. 2006 Jan;13(1):72-6. PubMed: 16420395PAPER Roth DL, Mittelman MS, Clay OJ, Madan A, Haley WE
Changes in social support as mediators of the impact of a psychosocial intervention for spouse caregivers of persons with Alzheimer's disease.
Psychol Aging. 2005 Dec;20(4):634-44. PubMed: 16420138PAPER Alvarez XA, Cacabelos R, Laredo M, Couceiro V, Sampedro C, Varela M, Corzo L, Fernandez-Novoa L, Vargas M, Aleixandre M, Linares C, Granizo E, Muresanu D, Moessler H
A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease.
Eur J Neurol. 2006 Jan;13(1):43-54. PubMed: 16420392PAPER Bastianetto S, Yao ZX, Papadopoulos V, Quirion R
Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity.
Eur J Neurosci. 2006 Jan;23(1):55-64. PubMed: 16420415PAPER Ohno M, Chang L, Tseng W, Oakley H, Citron M, Klein WL, Vassar R, Disterhoft JF
Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Eur J Neurosci. 2006 Jan;23(1):251-60. PubMed: 16420434PAPER de Groot NS, Aviles FX, Vendrell J, Ventura S
Mutagenesis of the central hydrophobic cluster in Abeta42 Alzheimer's peptide. Side-chain properties correlate with aggregation propensities.
FEBS J. 2006 Feb;273(3):658-68. PubMed: 16420488PAPER Kurko D, Boros A, Dezso P, Urbányi Z, Sárvári M, Nagy J, Szombathelyi Z, Szendrei GI
Flow cytometry-based method to analyze the change in Tau phosphorylation in a hGSK-3beta and hTau over-expressing EcR-293 cell line.
Neurochem Int. 2006 Apr;48(5):374-82. PubMed: 16420965PAPER Fu X, Ping Q, Gao Y
Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres.
J Microencapsul. 2005 Nov;22(7):705-14. PubMed: 16421082Current Filters
- Date Range : All x